Two Phase 3 clinical trials testing Tyvaso (treprostinil) in people with idiopathic pulmonary fibrosis (IPF) both met their ...

Columnist Ann Reynoso says she can't get used to the chronic cough of PF, but she's working to overcome the fear and ...

As he navigates his rare disease journey, columnist Samuel Kirton feels it is his responsibility to be a "five-star patient." ...

Brainomix and Boehringer Ingelheim will advance testing of an AI-based analysis tool that may enable earlier diagnosis of PF.

Columnist Sam Kirton began taking Ozempic to manage his blood sugar and CKD, but losing weight has been a welcome secondary benefit.

Authorities in China have given a green light to an early clinical trial testing inhaled rentosertib for IPF in patients and volunteers.

Enrollment has finished ahead of schedule in a Phase 2 clinical trial testing Calluna Pharma‘s experimental antibody therapy CAL101 in people with idiopathic pulmonary fibrosis (IPF). The Phase 2 ...

The U.S. Food and Drug Administration (FDA) has approved a generic version of Ofev (nintedanib) for easing lung scarring in people with idiopathic pulmonary fibrosis (IPF). The new generic nintedanib ...

In 2019 Christie Patient relocated to San Francisco to care for her mother, Holly, before and after her double-lung transplant. Holly’s idiopathic pulmonary fibrosis diagnosis came only months before ...

Treatment with the experimental oral therapy GRI-0621 modulated immune cell activity in adults with idiopathic pulmonary fibrosis (IPF) in an early Phase 2a clinical trial, according to new data ...

Building on positive Phase 2 data, Puretech Health plans to launch a Phase 3 trial in the coming months to further test its experimental oral therapy deupirfenidone (LYT-100) in people with idiopathic ...